Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TISLELIZUMAB vs TISOTUMAB VEDOTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TISLELIZUMAB vs TISOTUMAB VEDOTIN: Safety Overview

Metric TISLELIZUMAB TISOTUMAB VEDOTIN
Total FAERS Reports 4,996 166
Deaths Reported 114 16
Death Rate 2.3% 9.6%
Hospitalizations 2,586 101
Average Patient Age 62.9 yrs 50.4 yrs
% Female Patients 26.5% 88.8%
Manufacturer BeOne Medicines USA, Inc. SEAGEN INC.
Route INTRAVENOUS INTRAVENOUS